Research ArticleArticle
Open Access
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven, Paul Emery, Clifton O Bingham III, Edward C. Keystone, Roy Fleischmann, Daniel E. Furst, Katherine Macey, Marianne Sweetser, Ariella Kelman and Ravi Rao
The Journal of Rheumatology January 2010, jrheum.090856; DOI: https://doi.org/10.3899/jrheum.090856
Ronald F. van Vollenhoven
Paul Emery
Clifton O Bingham III
Edward C. Keystone
Roy Fleischmann
Daniel E. Furst
Katherine Macey
Marianne Sweetser
Ariella Kelman
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven, Paul Emery, Clifton O Bingham, Edward C. Keystone, Roy Fleischmann, Daniel E. Furst, Katherine Macey, Marianne Sweetser, Ariella Kelman, Ravi Rao
The Journal of Rheumatology Jan 2010, jrheum.090856; DOI: 10.3899/jrheum.090856
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven, Paul Emery, Clifton O Bingham, Edward C. Keystone, Roy Fleischmann, Daniel E. Furst, Katherine Macey, Marianne Sweetser, Ariella Kelman, Ravi Rao
The Journal of Rheumatology Jan 2010, jrheum.090856; DOI: 10.3899/jrheum.090856